| Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes M Battaglia, S Ahmed, MS Anderson, MA Atkinson, D Becker, PJ Bingley, ... Diabetes care 43 (1), 5-12, 2020 | 263 | 2020 |
| Rational design of small molecules as vaccine adjuvants TYH Wu, M Singh, AT Miller, E De Gregorio, F Doro, U D’Oro, ... Science translational medicine 6 (263), 263ra160-263ra160, 2014 | 186 | 2014 |
| Combination vaccines DAG Skibinski, BC Baudner, M Singh, D T O’Hagan Journal of global infectious diseases 3 (1), 63-72, 2011 | 131 | 2011 |
| Regulation of the Hydrogenase-4 Operon of Escherichia coli by the σ54-Dependent Transcriptional Activators FhlA and HyfR DAG Skibinski, P Golby, YS Chang, F Sargent, R Hoffman, R Harper, ... Journal of bacteriology 184 (23), 6642-6653, 2002 | 113 | 2002 |
| Approach to discover T-and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines O Finco, E Frigimelica, F Buricchi, R Petracca, G Galli, E Faenzi, E Meoni, ... Proceedings of the National Academy of Sciences 108 (24), 9969-9974, 2011 | 98 | 2011 |
| Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate A Kabanova, I Margarit, F Berti, MR Romano, G Grandi, G Bensi, ... Vaccine 29 (1), 104-114, 2010 | 93 | 2010 |
| Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian … JGH Low, LS Lee, EE Ooi, K Ethirajulu, P Yeo, A Matter, JE Connolly, ... Vaccine 32 (39), 5041-5048, 2014 | 79 | 2014 |
| Aluminum adjuvant dose guidelines in vaccine formulation for preclinical evaluations S Vecchi, S Bufali, DAG Skibinski, DT O'hagan, M Singh Journal of pharmaceutical sciences 101 (1), 17-20, 2012 | 79 | 2012 |
| Compounds and compositions as TLR activity modulators TYH Wu, Y Li, A Cortez, K Yue, X Zhang, M Singh, D Skibinski US Patent 9,045,470, 2015 | 78 | 2015 |
| Patterns of polymorphism and gene flow of gender‐associated mitochondrial DNA lineages in European mussel populations H Quesada, C Gallagher, DAG Skibinski, DOF Skibinski Molecular Ecology 7 (8), 1041-1051, 1998 | 59 | 1998 |
| Compounds and compositions as TLR activity modulators M Singh, D Skibinski, S Cianetti, D Francesco, S Jain US Patent 9,950,062, 2018 | 48 | 2018 |
| A Helicobacter pylori Vacuolating Toxin Mutant That Fails To Oligomerize Has a Dominant Negative Phenotype C Genisset, CL Galeotti, P Lupetti, D Mercati, DAG Skibinski, S Barone, ... Infection and immunity 74 (3), 1786-1794, 2006 | 46 | 2006 |
| Incorporation of phosphonate into benzonaphthyridine toll-like receptor 7 agonists for adsorption to aluminum hydroxide A Cortez, Y Li, AT Miller, X Zhang, K Yue, J Maginnis, J Hampton, DS Hall, ... Journal of medicinal chemistry 59 (12), 5868-5878, 2016 | 45 | 2016 |
| Vaccine design: innovative approaches and novel strategies R Rappuoli, F Bagnoli (No Title), 2011 | 45 | 2011 |
| Sex-biased heteroplasmy and mitochondrial DNA inheritance in the musselMytilus galloprovincialis Lmk. H Quesada, DAG Skibinski, DOF Skibinski Current Genetics 29, 423-426, 1996 | 43 | 1996 |
| Flow cytometry: an alternative method for direct quantification of antigens adsorbed to aluminum hydroxide adjuvant M Ugozzoli, D Laera, S Nuti, DAG Skibinski, S Bufali, C Sammicheli, ... Analytical biochemistry 418 (2), 224-230, 2011 | 38 | 2011 |
| Induction of human T-cell and cytokine responses following vaccination with a novel influenza vaccine DAG Skibinski, LA Jones, YO Zhu, LW Xue, B Au, B Lee, ANM Naim, ... Scientific reports 8 (1), 18007, 2018 | 37 | 2018 |
| CT043, a Protective Antigen That Induces a CD4+ Th1 Response during Chlamydia trachomatis Infection in Mice and Humans E Meoni, E Faenzi, E Frigimelica, L Zedda, D Skibinski, S Giovinazzi, ... Infection and immunity 77 (9), 4168-4176, 2009 | 35 | 2009 |
| The Cell-Specific Phenotype of the Polymorphic vacA Midregion Is Independent of the Appearance of the Cell Surface Receptor Protein Tyrosine Phosphatase β DAG Skibinski, C Genisset, S Barone, JL Telford Infection and immunity 74 (1), 49-55, 2006 | 34 | 2006 |
| The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity H Bolouri, C Speake, D Skibinski, SA Long, AM Hocking, DJ Campbell, ... The Journal of Clinical Investigation 131 (3), 2021 | 33 | 2021 |
Manmohan SinghBeam TxVerified email at beamtx.com
